Farmex Europejska i Spółka z Ograniczoną Odpowiedzialnością (KRS 0000680768, NIP 5213783744) is a Polish company, headquartered in Łódź, Łódzkie voivodeship. FARMEX EUROPEJSKA I operates in: Dispensing chemist in specialised stores (PKD 47.73.Z). Industry: Retail trade. The company has been listed in the National Court Register since May 31, 2017. FARMEX EUROPEJSKA I's most recently reported net revenue was 5.1 M PLN for 2024.
Negative equity
Negative equity in 7 of 7 available reporting years.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Business profile - Farmex Europejska i
Identity
- Name
- Farmex Europejska i Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- May 31, 2017
- Registry status as of
- June 8, 2026
- Latest entry
- June 8, 2026
- Founding act
- 06 KWIETNIA 2017 R., NOTARIUSZ EWA BRUDNICKA, KANCELARIA NOTARIALNA W WARSZAWIE, REP. A NR 1678/2017
Articles of association history (2)
- 06 KWIETNIA 2017 R., NOTARIUSZ EWA BRUDNICKA, KANCELARIA NOTARIALNA W WARSZAWIE, REP. A NR 1678/2017
- 13 WRZEŚNIA 2024 R., REP. A NR 3867/2024, NOTARIUSZ BARTŁOMIEJ JANICKI, KANCELARIA NOTARIALNA W ALEKSANDROWIE ŁÓDZKIM, ZMIANA TREŚCI UMOWY SPÓŁKI POPRZEZ NADANIE JEJ NOWEGO BRZMIENIA
Activities
Main activity
47.73.ZDispensing chemist in specialised stores
Other activities
Address and contact
- Address
- UL. KINGA C. GILLETTE, 11, 94-406, ŁÓDŹ, POLSKA
- Voivodeship
- ŁÓDZKIE
- District
- ŁÓDŹ
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- AE:PL-14603-84853-FFTIE-27
Risk and payment profile - Farmex Europejska i
Credibility rating
24.4 / 100
Poor credibility
Insolvency risk
Moderate
Significant formal threat
Closure risk
30
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organizational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
1
1/9 yrs
Board changes
4
4/9 yrs
PKD changes
1
1/9 yrs
Name changes
1
1/9 yrs
Data from 9 years of registry activity.
Credibility history
Payment reliability score from 2018–2024
Current: E (24/100)
Trend: stable (0.0 pts/year)
Bardzo słaba wiarygodność płatnicza – współpraca handlowa wiąże się z wysokim ryzykiem braku zapłaty.
Trade credit limit history
Standard limit from 2018–2024
Current: 74.9 K PLN
Safe: 12.7 K PLN
Operational status - Farmex Europejska i
Founded
May 31, 2017
9 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
ŁÓDŹ
ŁÓDZKIE
Primary PKD
47.73.Z
Dispensing chemist in specialised stores
Share capital
5.0 K PLN
100 shares total
Shareholders
1
shareholder
Board
3 people
Filed years
7 years
2018–2024 · profitable: 0/7
Registry entries
32
latest: June 8, 2026
Risk signals
Revenue
5.1 M PLN
2024
Net profit
-138.5 K PLN
2024
Assets
902.3 K PLN
2024
Equity
-1.3 M PLN
2024
EBITDA
N/A
2024
no depreciation data
Valuation
626.2 K PLN
Low confidence
Low confidence
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - Farmex Europejska i.
No ratings
Related articles
News
Ambra in 2026: PLN 48.1 m capex (+212%), PLN 1.10 dividend three years running, Cydr Lubelski plus Romanian Zarea as the premium engine
Warsaw-based Ambra S.A. (KRS 0000041726, ul. Puławska 336) closed H1 of fiscal 2025/2026 with PLN 556.8 m of revenue and PLN 49.0 m of net profit, while raising capex by 212% to PLN 48.1 m - mainly for the soft-drinks line in Wola Duża and the PLN 11.9 m acquisition of a Romanian company. Despite the aggressive investment cycle the board keeps a PLN 1.10 dividend per share for the third year running (~5.9% yield).
News
Answear in 2026: first full year without MCI, PLN 9.3 m net profit, but the supervisory board cuts the 2026 EBITDA target from PLN 100 m to PLN 90 m
Kraków-based Answear.com S.A. (KRS 0000816066) closed 2025 with revenue of PLN 1.7 bn (+13% YoY), EBITDA of PLN 56 m (+63%) and net profit of PLN 9.3 m - a return to the black after a PLN 10 m loss in 2024. Poland grew +31%, but CEE was under FX pressure (hryvnia -11% vs PLN), and a weak Q4 (EBITDA -71% YoY) forced the supervisory board to cut the 2026 EBITDA target from PLN 100 m to PLN 90 m and the target price from PLN 50 to PLN 45. It is the first full year after MCI's exit from the shareholder base (10 June 2025); the Bajołek brothers retain control (57.8%).
